<p>即使在未来，蓝筹股仍然是所有可用股票中最可靠的之一。这是因为它们属于具有稳健财务和增长潜力的企业和公司。对于寻求进行低风险、稳定投资并在长期内获得巨大回报的投资者来说，它们也是完美的选择。</p>
<p>尽管如此，许多蓝筹股市值较高，投资于它们可能需要大量资本，而大多数投资者要么没有这么多资本，要么不愿意投入。这样的投资者应该转向未来的蓝筹股，这些股票通常更便宜，具有相同的优质特质。</p>
<p>本文重点介绍了三只未来蓝筹股，可能在今年下半年及以后带来巨大的股息。</p>
<h2>沃尔玛（WMT）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>图片来源：Jonathan Weiss / Shutterstock.com</p>
<p><strong>沃尔玛</strong>（纽约证券交易所：<strong>WMT</strong>）是一家美国零售巨头，拥有遍布全国的大卖场、折扣百货商店和杂货店。在零售业中，有几家公司的市场份额比沃尔玛更大，尤其是在美国市场，沃尔玛控制着大部分市场份额。</p>
<p>尽管在美国零售市场占据牢固地位，沃尔玛表现出继续增长和改进产品和服务范围的承诺。在过去几年中，它推出了多项扩大业务的举措，例如推出订阅服务 Walmart+。还有传言称其有意收购知名电视制造商 Vizio。</p>
<p>沃尔玛增长潜力的另一个例子是其持续的扩张努力。该公司预计在未来五年内将在美国开设或改建 100 多家门店。这些门店可能会继续保持沃尔玛的传统，如大型促销活动、价格优惠和折扣。</p>
<p>在财务方面，沃尔玛又度过了一个高盈利的一年。根据其最新季度报告，该公司的综合收入增长了 6%，创造了令人瞩目的 1615 亿美元。</p>
<p>此外，其电子商务和广告业务也实现了显著增长，分别增长了 21% 和 24%。</p>
<h2>摩根大通（JEF）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>图片来源：T. Schneider/ShutterStock.com</p>
<p><strong>摩根大通金融集团</strong>（纽约证券交易所：<strong>JEF</strong>）是一家总部位于纽约的独立投资银行和金融服务提供商。它是投资银行和资本市场领域的全球领导者，在投资银行、全球研究与策略、另类资产管理、财富管理、股票和固定收益等各个领域拥有深厚的专业知识。</p>
<p>摩根大通金融集团是盈利的典范。自 1983 年上市以来，该银行的回报率是标普 500 指数的两倍，100 美元的投资现在价值 12775 美元。</p>
<p>此外，像大多数蓝筹公司一样，摩根大通金融集团以支付和增长股息而闻名。它的股息不仅每年产生 2.8% 的收益，而且在过去五年中以 22% 的复合年增长率增加了股息，使其成为市场上收益最高的股票之一。</p>
<p>从银行的财务状况来看，根据其最新季度报告，摩根大通金融集团度过了一个出色的一年，在收入和利润等关键指标上取得了令人瞩目的成绩。它创造了 16.6 亿美元的净收入，并将季度现金股息提高了 16.7%。</p>
<h2>礼来（LLY）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>图片来源：shutterstock.com/Michael Vi</p>
<p><strong>礼来</strong>（纽约证券交易所：<strong>LLY</strong>）是一家总部位于印第安纳波利斯的制药公司。它以生产治疗癌症、糖尿病、骨骼肌肉关节、心血管、内分泌、免疫学、神经科学和肥胖症等领域的药物而闻名。其药物也在全球 100 多个国家提供。</p>
<p>由于其在各种治疗领域的多样化业务和产品，礼来成为一个具有高潜力的蓝筹股。特别是在糖尿病和肥胖控制领域，得益于其旗舰糖尿病治疗药物 Trulicity 的成功。</p>
<p>根据其最新季度报告，该药物仅在今年第一季度就产生了 15 亿美元的收入。报告还显示，公司最新的糖尿病药物 Mounjaro 在同一时期也表现良好，产生了 18 亿美元的收入。</p>
<p>另一种类似于 Mounjaro 但也治疗减肥的药物 Zepbound，在今年第一季度也产生了 5.17 亿美元的收入。</p>
<p>以 7300 亿美元的市值，礼来是制药行业中最盈利丰厚的公司之一，也是最有价值的医疗保健股票之一。</p>
<p><em>在本文发布日期，Joel Lim 对本文提及的证券没有（直接或间接）任何持仓。本文中表达的观点属于作者个人，遵守 InvestorPlace.com 的发布准则。</em></p>
<p><em>在本文发布日期，负责编辑对本文提及的证券没有（直接或间接）任何持仓。</em></p>
<p>Joel Lim 是 InvestorPlace.com 的撰稿人，也是一名金融内容承包商，为 LTSE 和 Realtor 等多家公司以及 Business Insider、Yahoo Finance、Mises Institution 和 Foundation for Economic Education 等金融出版物创作内容。</p>
<p>消费者自由裁量权、金融、医疗保健、零售</p>
<p>蓝筹股</p>

沃尔玛

挚文集团

礼来

<p>沃尔玛、挚文集团和礼来是三只未来有潜力获得高回报的蓝筹股。沃尔玛不断扩大和改进其产品和服务，而挚文集团具有良好的盈利记录和股息增长。礼来以其多样化的制药产品而闻名，特别是在糖尿病和肥胖控制领域。这些股票为投资者提供了稳定且低风险的投资机会，同时具有可观的股息潜力</p>

<p>Even in the future, blue-chip stocks will be among the most reliable of all the available stocks. That’s because they belong to businesses and companies with solid financials and growth potential. They are also the perfect options for investors looking to make low-risk, stable investments that will yield massive returns over the long run.</p>
<div class="lb-trans"><p>即使在未来，蓝筹股仍然是所有可用股票中最可靠的之一。这是因为它们属于具有稳健财务和增长潜力的企业和公司。对于寻求进行低风险、稳定投资并在长期内获得巨大回报的投资者来说，它们也是完美的选择。</p>
</div><p>While that is the case, many blue-chip stocks are high-cap, and investing in them may take a lot of capital that most investors simply do not have or are unwilling to fork out. Such investors should look towards future blue-chip stocks, which are often cheaper and possess the same qualities.</p>
<div class="lb-trans"><p>尽管如此，许多蓝筹股市值较高，投资于它们可能需要大量资本，而大多数投资者要么没有这么多资本，要么不愿意投入。这样的投资者应该转向未来的蓝筹股，这些股票通常更便宜，具有相同的优质特质。</p>
</div><p>This article highlights three future blue-chip stocks that could yield huge dividends in the second half of the year and beyond.</p>
<div class="lb-trans"><p>本文重点介绍了三只未来蓝筹股，可能在今年下半年及以后带来巨大的股息。</p>
</div><h2>Walmart (WMT)</h2>
<div class="lb-trans"><h2>沃尔玛（WMT）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: Jonathan Weiss / Shutterstock.com</p>
<div class="lb-trans"><p>图片来源：Jonathan Weiss / Shutterstock.com</p>
</div><p><strong>Walmart</strong> (NYSE: <strong>WMT</strong>) is an American retail giant with a chain of hypermarkets, discount department stores and grocery stores scattered across the country. There are a handful of companies in the retail business with a more substantial presence than Walmart, especially in the American market, where it controls most of the market share.</p>
<div class="lb-trans"><p><strong>沃尔玛</strong>（纽约证券交易所：<strong>WMT</strong>）是一家美国零售巨头，拥有遍布全国的大卖场、折扣百货商店和杂货店。在零售业中，有几家公司的市场份额比沃尔玛更大，尤其是在美国市场，沃尔玛控制着大部分市场份额。</p>
</div><p>Despite its firm grip on the American retail scene, Walmart has shown a commitment to continuing to grow and improve the range of its products and services. Over the last few years, it has launched several efforts to expand its business, such as the launch of its subscription service, Walmart+. There is also talk of acquiring popular television maker Vizio.</p>
<div class="lb-trans"><p>尽管在美国零售市场占据牢固地位，沃尔玛表现出继续增长和改进产品和服务范围的承诺。在过去几年中，它推出了多项扩大业务的举措，例如推出订阅服务 Walmart+。还有传言称其有意收购知名电视制造商 Vizio。</p>
</div><p>Another example of Walmart’s growth potential is its consistent expansion efforts. The company anticipates opening or converting over 100 stores across the US in the next five years. These stores will likely continue popular Walmart traditions, such as massive sales events, price slashes and discounts.</p>
<div class="lb-trans"><p>沃尔玛增长潜力的另一个例子是其持续的扩张努力。该公司预计在未来五年内将在美国开设或改建 100 多家门店。这些门店可能会继续保持沃尔玛的传统，如大型促销活动、价格优惠和折扣。</p>
</div><p>On the financial front, Walmart is enjoying yet another year of high profitability. According to its latest quarterly report, the company saw a 6% increase in its consolidated revenue, generating an impressive $161.5 billion.</p>
<div class="lb-trans"><p>在财务方面，沃尔玛又度过了一个高盈利的一年。根据其最新季度报告，该公司的综合收入增长了 6%，创造了令人瞩目的 1615 亿美元。</p>
</div><p>Furthermore, its e-commerce and advertising business also grew significantly, increasing by 21% and 24%, respectively.</p>
<div class="lb-trans"><p>此外，其电子商务和广告业务也实现了显著增长，分别增长了 21% 和 24%。</p>
</div><h2>Jefferies Financial Group (JEF)</h2>
<div class="lb-trans"><h2>摩根大通（JEF）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: T. Schneider/ShutterStock.com</p>
<div class="lb-trans"><p>图片来源：T. Schneider/ShutterStock.com</p>
</div><p><strong>Jefferies Financial Group</strong>(NYSE: <strong>JEF</strong>) is an independent investment bank and financial services provider based in New York, New York. It is a global leader in the investment banking and capital markets scene and boasts deep expertise in various sectors, such as investment banking, global research and strategy, alternative asset management, wealth management, equities, and fixed income.</p>
<div class="lb-trans"><p><strong>摩根大通金融集团</strong>（纽约证券交易所：<strong>JEF</strong>）是一家总部位于纽约的独立投资银行和金融服务提供商。它是投资银行和资本市场领域的全球领导者，在投资银行、全球研究与策略、另类资产管理、财富管理、股票和固定收益等各个领域拥有深厚的专业知识。</p>
</div><p>Jefferies Financial Group is a beacon of profitability. Since going public in 1983, the bank has doubled the returns of the S&amp;P 500, with $100 invested, then being $12,775 now.</p>
<div class="lb-trans"><p>摩根大通金融集团是盈利的典范。自 1983 年上市以来，该银行的回报率是标普 500 指数的两倍，100 美元的投资现在价值 12775 美元。</p>
</div><p>Furthermore, like most blue-chip companies, Jefferies Financial Group is well known for paying and growing its dividend. Not only do its dividends yield 2.8% a year, but it has increased the payout at a compounded annual growth rate of 22% in the last five years, making it one of the highest-yielding stocks on the market.</p>
<div class="lb-trans"><p>此外，像大多数蓝筹公司一样，摩根大通金融集团以支付和增长股息而闻名。它的股息不仅每年产生 2.8% 的收益，而且在过去五年中以 22% 的复合年增长率增加了股息，使其成为市场上收益最高的股票之一。</p>
</div><p>A look at the bank’s finances paints the whole picture. According to its latest quarterly report, Jefferies Financial Group has enjoyed a great year, generating impressive numbers across key metrics like revenue and income. It generated a net revenue of $1.66 billion and increased its quarterly cash dividend by 16.7%.</p>
<div class="lb-trans"><p>从银行的财务状况来看，根据其最新季度报告，摩根大通金融集团度过了一个出色的一年，在收入和利润等关键指标上取得了令人瞩目的成绩。它创造了 16.6 亿美元的净收入，并将季度现金股息提高了 16.7%。</p>
</div><h2>Eli Lilly (LLY)</h2>
<div class="lb-trans"><h2>礼来（LLY）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: shutterstock.com/Michael Vi</p>
<div class="lb-trans"><p>图片来源：shutterstock.com/Michael Vi</p>
</div><p><strong>Eli Lilly</strong>(NYSE:<strong>LLY</strong>) is a pharmaceutical company based in Indianapolis, Indiana. It is notable for producing medicine for treatments in areas such as cancer, diabetes, bone muscle joint, cardiovascular, endocrine, immunology, neuroscience and obesity. Its drugs are also available in over 100 countries across the globe.</p>
<div class="lb-trans"><p><strong>礼来</strong>（纽约证券交易所：<strong>LLY</strong>）是一家总部位于印第安纳波利斯的制药公司。它以生产治疗癌症、糖尿病、骨骼肌肉关节、心血管、内分泌、免疫学、神经科学和肥胖症等领域的药物而闻名。其药物也在全球 100 多个国家提供。</p>
</div><p>Thanks to its diverse business and offerings across various therapeutic areas, Eli Lilly emerges as a blue-chip stock with high potential. It is especially bullish in the diabetes and obesity control sector thanks to the success of its flagship diabetes treatment, Trulicity.</p>
<div class="lb-trans"><p>由于其在各种治疗领域的多样化业务和产品，礼来成为一个具有高潜力的蓝筹股。特别是在糖尿病和肥胖控制领域，得益于其旗舰糖尿病治疗药物 Trulicity 的成功。</p>
</div><p>According to its latest quarterly report, the drug generated $1.5 billion in revenue in the first quarter of the year only. The report also indicates that the company’s newest diabetes drug, Mounjaro, is also performing well in the market, generating $1.8 billion in revenue in the same period.</p>
<div class="lb-trans"><p>根据其最新季度报告，该药物仅在今年第一季度就产生了 15 亿美元的收入。报告还显示，公司最新的糖尿病药物 Mounjaro 在同一时期也表现良好，产生了 18 亿美元的收入。</p>
</div><p>Another treatment, Zepbound, which is similar to Mounjaro but also treats weight loss, generated $517 million in the first quarter of the year as well.</p>
<div class="lb-trans"><p>另一种类似于 Mounjaro 但也治疗减肥的药物 Zepbound，在今年第一季度也产生了 5.17 亿美元的收入。</p>
</div><p>With a market cap of $730 billion, Eli Lilly is one of the most profitable companies in the pharmaceutical industry and one of the most valuable healthcare stocks.</p>
<div class="lb-trans"><p>以 7300 亿美元的市值，礼来是制药行业中最盈利丰厚的公司之一，也是最有价值的医疗保健股票之一。</p>
</div><p><em>On the date of publication, Joel Lim did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.</em></p>
<div class="lb-trans"><p><em>在本文发布日期，Joel Lim 对本文提及的证券没有（直接或间接）任何持仓。本文中表达的观点属于作者个人，遵守 InvestorPlace.com 的发布准则。</em></p>
</div><p><em>On the date of publication, the responsible editor did not have (either directly or</em></p>
<p><em>indirectly) any positions in the securities mentioned in this article.</em></p>
<div class="lb-trans"><p><em>在本文发布日期，负责编辑对本文提及的证券没有（直接或间接）任何持仓。</em></p>
</div><p>Joel Lim is a contributor at InvestorPlace.com and a finance content contractor who creates content for several companies like LTSE and Realtor, along with financial publications, including Business Insider, Yahoo Finance, Mises Institution and Foundation for Economic Education.</p>
<div class="lb-trans"><p>Joel Lim 是 InvestorPlace.com 的撰稿人，也是一名金融内容承包商，为 LTSE 和 Realtor 等多家公司以及 Business Insider、Yahoo Finance、Mises Institution 和 Foundation for Economic Education 等金融出版物创作内容。</p>
</div><p>Consumer Discretionary, Financial, Healthcare, Retail</p>
<div class="lb-trans"><p>消费者自由裁量权、金融、医疗保健、零售</p>
</div><p>Blue-Chip Stocks</p>
<div class="lb-trans"><p>蓝筹股</p>
</div>

3 Future Blue-Chip Stocks That Could Make You Rich

- 蓝筹股将来仍将是所有可用股票中最可靠的之一，因为它们属于财务稳健且具有增长潜力的企业和公司。
- 即使如此，许多蓝筹股市值较高，投资可能需要大量资本，而大多数投资者可能没有或不愿意投入。这些投资者应该关注未来的蓝筹股，通常价格更便宜且具有相同的品质。
- 本文重点介绍了可能在下半年及以后获得巨额股息的三只未来蓝筹股：沃尔玛（WMT）、Jefferies Financial Group（JEF）和 Eli Lilly（LLY）。

3 只未来可能让你致富的蓝筹股